Literature DB >> 33249529

Protective effect of lncRNA CRNDE on myocardial cell apoptosis in heart failure by regulating HMGB1 cytoplasm translocation through PARP-1.

Hui Chen1, Jinming Liu1, Bin Wang1, Yongjun Li2.   

Abstract

Long non-coding RNAs (lncRNAs) are bound up with the regulation of various diseases. Here, we probed into the effect of lncRNA colorectal neoplasia differentially expressed (CRNDE) on heart failure (HF). The pathological alterations and cell apoptosis of heart tissues were observed by hematoxylin-eosin and TUNEL staining. The viability or apoptosis of mouse myocardial cells HL-1 was tested by XTT or flow cytometry. The interaction between lncRNA CRNDE and poly-ADP-ribose polymerase 1 (PARP-1) was verified by RNA immunoprecipitation and RNA pull-down. The stability of the PARP-1 protein and the acetylation level of high mobility group box-1 (HMGB1) were determined by cycloheximide-chase and immunoprecipitation, respectively. LncRNA CRNDE expression was decreased in HF mice tissues and doxorubicin (Dox)-treated HL-1 cells, whereas PARP-1 and HMGB1 were increased. The overexpression of lncRNA CRNDE restrained HL-1 cell apoptosis induced by Dox. Moreover, the interaction between CRNDE and PARP-1 was corroborated, CRNDE negatively regulated PARP-1 expression, and the overexpression of CRNDE reduced PARP-1 protein stability. In HL-1 cells, PARP-1 positively regulated the acetylation level and cytoplasm translocation of HMGB1. CRNDE restrained Dox-induced apoptosis in mouse myocardial cells via the PARP-1/HMGB1 pathway.

Entities:  

Keywords:  HF; HMGB1; LncRNA CRNDE; Myocardial cell; PARP-1

Mesh:

Substances:

Year:  2020        PMID: 33249529     DOI: 10.1007/s12272-020-01290-7

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  3 in total

1.  Effects of Wenyang Zhenshuai Granules on the Expression of Key Mitochondrial Autophagy Proteins in the Doxorubicin-Induced Model of H9c2 Cardiomyocyte Injury.

Authors:  L Q Peng; X X Wu; G Chen; H Z Cai; Y P Tang; Q Y Chen; X Y Chen
Journal:  Bull Exp Biol Med       Date:  2022-07-20       Impact factor: 0.737

Review 2.  LncRNAs at the heart of development and disease.

Authors:  Kelly M Anderson; Douglas M Anderson
Journal:  Mamm Genome       Date:  2022-01-20       Impact factor: 2.957

Review 3.  Non-coding RNAs in cancer therapy-induced cardiotoxicity: Mechanisms, biomarkers, and treatments.

Authors:  Wanli Sun; Juping Xu; Li Wang; Yuchen Jiang; Jingrun Cui; Xin Su; Fan Yang; Li Tian; Zeyu Si; Yanwei Xing
Journal:  Front Cardiovasc Med       Date:  2022-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.